Professor Georgina Long named as one of world's most highly cited researchers
4 December 2018
Melanoma Institute Australia’s Co-Medical Director Professor Georgina Long has been included in the 2018 Clarivate Analytics Highly Cited Researchers List in recognition of her global leadership in melanoma research and clinical trials.
Professor Long is one of only 12 researchers from The University of Sydney to be listed in the top one percent of researchers in their field. Professor Long was named in the Clinical Medicine category for her extensive work in melanoma research and clinical trials.
‘This is an outstanding achievement and great recognition of the global impact of Professor Long’s research, particularly in clinical trials,’ said fellow MIA Co-Medical Director Professor Richard Scolyer. ‘We are exceptionally proud to have someone of Georgina’s calibre as part of our team which is changing the face of melanoma treatment around the world.’
Now in its 5th year, the Clarivate Analytics Highly Cited Researchers List names the most influential researchers impacting their chosen fields, measured by rate of citation by their peers. Other researchers on the list include one of this year’s Nobel Laureates in Physiology or Medicine, Professor James P. Allison.
The Academic Ranking of World Universities uses the Highly Cited Researchers List to calculate the Highly Cited Score, which contributes to an institutions overall rank. This year, The University of Sydney climbed 15 places to its highest rank so far, due in no small part to research output of Professor Long and the other 11 researchers.
"International collaboration remains the key to ensuring this pioneering research continues so we can increase survival rates for advanced melanoma patients and move us closer to achieving our goal of zero deaths from melanoma," says Professor Georgina Long, of the clinical trial results presented at ESMO 2018.
Research that could change clinical practice for high-risk Stage III melanoma patients has been presented at the European Society for Medical Oncology (ESMO) Congress in Munich.
A larger, monthly dose of immunotherapy can give melanoma patients more freedom without sacrificing effectiveness.
The Australasian Melanoma Conference, hosted by the Australasian Melanoma Conference Committee, was held in Melbourne on the weekend, with many of MIA's clinicians in attendance.
The two men who discovered checkpoint inhibitors, the brakes of the immune system, were awarded the Nobel Prize in Physiology or Medicine on Monday, October 1.
The World Health Organisation (WHO) is releasing the 4th edition of Classification of Skin Tumours.
Former Executive Director of Melanoma Institute Australia Professor John Thompson awarded the prestigious 2018 RPA Foundation Research Medal.
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.
The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.
Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.